Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

[Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition].

Kim SG, Jung HK, Lee HL, Jang JY, Lee H, Kim CG, Shin WG, Shin ES, Lee YC; Korean College of Helicobacter and Upper Gastrointestinal Research.

Korean J Gastroenterol. 2013 Jul;62(1):3-26. Korean.

2.

Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition.

Kim SG, Jung HK, Lee HL, Jang JY, Lee H, Kim CG, Shin WG, Shin ES, Lee YC; Korean College of Helicobacter and Upper Gastrointestinal Research.

J Gastroenterol Hepatol. 2014;29(7):1371-86. doi: 10.1111/jgh.12607. Review.

PMID:
24758240
3.

[Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea].

Kim N, Kim JJ, Choe YH, Kim HS, Kim JI, Chung IS; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Association of Gastroenterology.

Korean J Gastroenterol. 2009 Nov;54(5):269-78. Korean.

4.

[Helicobacter pylori eradication therapy in Korea].

Kim SY, Jung SW.

Korean J Gastroenterol. 2011 Dec;58(2):67-73. Review. Korean.

5.

Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.

Zagari RM, Romano M, Ojetti V, Stockbrugger R, Gullini S, Annibale B, Farinati F, Ierardi E, Maconi G, Rugge M, Calabrese C, Di Mario F, Luzza F, Pretolani S, Savio A, Gasbarrini G, Caselli M.

Dig Liver Dis. 2015 Nov;47(11):903-12. doi: 10.1016/j.dld.2015.06.010. Epub 2015 Jul 6.

6.

The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea.

Chung JW, Lee GH, Han JH, Jeong JY, Choi KS, Kim DH, Jung KW, Choi KD, Song HJ, Jung HY, Kim JH.

Hepatogastroenterology. 2011 Jan-Feb;58(105):246-50.

PMID:
21510323
7.

Diagnosis and treatment of Helicobacter pylori infection.

Bytzer P, Dahlerup JF, Eriksen JR, Jarbøl DE, Rosenstock S, Wildt S; Danish Society for Gastroenterology.

Dan Med Bull. 2011 Apr;58(4):C4271. Review.

PMID:
21466771
8.

Guidelines in the medical treatment of Helicobacter pylori infection.

Dzieniszewski J, Jarosz M.

J Physiol Pharmacol. 2006 Sep;57 Suppl 3:143-54.

PMID:
17033112
9.

Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.

Lee HJ, Kim JI, Lee JS, Jun EJ, Oh JH, Cheung DY, Chung WC, Kim BW, Kim SS.

World J Gastroenterol. 2015 Jan 7;21(1):351-9. doi: 10.3748/wjg.v21.i1.351.

10.

[New guidelines for Helicobacter pylori treatment: comparisons between Korea and Japan].

Lee SY.

Korean J Gastroenterol. 2014 Mar 25;63(3):151-7. Review. Korean.

11.

Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.

Laine L, Estrada R, Trujillo M, Emami S.

Am J Gastroenterol. 1997 Dec;92(12):2213-5.

PMID:
9399755
12.

One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.

Sung JJ, Chan FK, Wu JC, Leung WK, Suen R, Ling TK, Lee YT, Cheng AF, Chung SC.

Aliment Pharmacol Ther. 1999 Aug;13(8):1079-84.

13.

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study Group and Consensus panel.

Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.

PMID:
27707777
14.

Management of Helicobacter pylori infection.

Costa F, D'Elios MM.

Expert Rev Anti Infect Ther. 2010 Aug;8(8):887-92. doi: 10.1586/eri.10.75. Review.

PMID:
20695744
15.

Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.

Zhang W, Chen Q, Liang X, Liu W, Xiao S, Graham DY, Lu H.

Gut. 2015 Nov;64(11):1715-20. doi: 10.1136/gutjnl-2015-309900. Epub 2015 Sep 2.

PMID:
26338726
16.

The efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in Korea.

Chung KH, Lee DH, Jin E, Cho Y, Seo JY, Kim N, Jeong SH, Kim JW, Hwang JH, Shin CM.

Gut Liver. 2014 Nov;8(6):605-11. doi: 10.5009/gnl13303. Epub 2014 Nov 15.

17.

[Helicobacter pylori. Update 2002].

Schuster MJ.

Praxis (Bern 1994). 2002 Nov 27;91(48):2093-9. Review. German.

PMID:
12508673
18.

Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea.

Lee H, Hong SN, Min BH, Lee JH, Rhee PL, Lee YC, Kim JJ.

Dig Liver Dis. 2015 Feb;47(2):114-8. doi: 10.1016/j.dld.2014.10.014. Epub 2014 Nov 15.

PMID:
25467826
19.

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ.

Gut. 2007 Jun;56(6):772-81. Epub 2006 Dec 14.

20.

[The several problems and cautions in treatment of Helicobacter pylori infection].

Fukuda Y, Sakagami T.

Gan To Kagaku Ryoho. 2004 Oct;31(10):1465-74. Review. Japanese.

PMID:
15508434

Supplemental Content

Support Center